We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Reset all filters
01 10ALFRED E TIEFENBACHER GmbH & Co KG
02 92Care4 Aps
03 6Abiogen Pharma S.P.A.
04 7G.L. Pharma Gmbh
05 5GL PHARMA GmbH
06 6GRUNENTHAL ITALIA Srl
07 13Gr?nenthal GmbH
08 32Gr?nenthal Gmbh
09 11Grünenthal GmbH
10 6Medical Valley Invest Ab
11 10Orifarm AS
12 5SANDOZ SPA
13 12Blank
Reset all filters
01 19 Tapentadol Tartrate
02 49Tapentadol
03 41Tapentadol Hydrochloride
04 23Tapentadol hydrochloride
Reset all filters
01 1Antic-calc Tablet, Film Coated
02 20Depot tablet
03 10Depottablett
04 10Extended Release Tablets
05 12Extended-Release Tablet
06 14Film Coated Tablet
07 2Mixture, solution
08 4Oral Solution
09 2Solution
10 45Tablet
11 1Tablet, film-coated
12 1Tapentadolo 100Mg 30 Joined' Oral Use Rp
13 1Tapentadolo 150Mg 30 Joined' Oral Use Rp
14 1Tapentadolo 200Mg 30 Joined' Oral Use Rp
15 1Tapentadolo 250Mg 30 Joined' Oral Use Rp
16 1Tapentadolo 25Mg 40 Combined Oral Use Rp
17 1Tapentadolo 50Mg 30 Joined' Oral Use Rp
18 5XR Tablet
Reset all filters
01 10Germany
02 16Italy
03 34Norway
04 12Spain
05 60Sweden
Reset all filters
01 160 Palexia Retard 100Mg Extended Release Tablets
02 160 Palexia Retard 150Mg Extended Release Tablets
03 160 Palexia Retard 200Mg Extended Release Tablets
04 160 Palexia Retard 250Mg Extended Release Tablets
05 160 Palexia Retard 25Mg Extended Release Tablets
06 160 Palexia Retard 50Mg Extended Release Tablets
07 160 Yantil Retard 100Mg Extended Release Tablets
08 160 Yantil Retard 150Mg Extended Release Tablets
09 160 Yantil Retard 200Mg Extended Release Tablets
10 160 Yantil Retard 250Mg Extended Release Tablets
11 160 Yantil Retard 25Mg Extended Release Tablets
12 160 Yantil Retard 50Mg Extended Release Tablets
13 3Ationdo
14 6Ationdo Depot
15 16Palexia
16 25Palexia Depot
17 20Palexia depot
18 5TADOMON
19 5TAPELOD
20 6Tapentadol Depot Abiogen
21 6Tapentadol Depot G.L. Pharma
22 6Tapentadol Depot Medical Valley
23 1Tapentadol Gl Pharma
24 5Yantil
25 6Yantil Depot
26 10Blank
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany